about
Cor pulmonalePulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management StrategiesPulmonary vasculature in COPD: The silent componentQuantitative pulmonary imaging using computed tomography and magnetic resonance imagingManaging comorbidities in COPDCardiopulmonary coupling in chronic obstructive pulmonary disease: the role of imaging.Pulmonary hypertension and right heart dysfunction in chronic lung disease.Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patientsImpact of pulmonary artery pressure on exercise function in severe COPD.The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous ratsAdenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary diseaseStudy design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstruRemodeling of rat pulmonary artery induced by chronic smoking exposure.Examination of pulse oximetry tracings to detect obstructive sleep apnea in patients with advanced chronic obstructive pulmonary disease.Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease.Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxidePulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management.Pulmonary hypertension in patients with treated pulmonary tuberculosis: analysis of 14 consecutive casesAn official American Thoracic Society Statement: pulmonary hypertension phenotypesVasodilatory effect of the stable vasoactive intestinal peptide analog RO 25-1553 in murine and rat lungsHypoxemia in patients with COPD: cause, effects, and disease progressionThe effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.Prevalence and clinical characteristics associated with pulmonary hypertension in African-Americans.One-year prognosis and the role of brain natriuretic peptide levels in patients with chronic cor pulmonaleHeme biosynthesis modulation via δ-aminolevulinic acid administration attenuates chronic hypoxia-induced pulmonary hypertension.Overview of current therapeutic approaches for pulmonary hypertension.Comparison of CT-Determined Pulmonary Artery Diameter, Aortic Diameter, and Their Ratio in Healthy and Diverse Clinical Conditions.Multi-detector CT assessment in pulmonary hypertension: techniques, systematic approach to interpretation and key findingsAcute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary diseaseOxygen desaturation during a 6 min walk test is a sign of nocturnal hypoxemia.A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary diseaseEnhanced store-operated Ca²+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema.Functional and Prognostic Implications of the Main Pulmonary Artery Diameter to Aorta Diameter Ratio from Chest Computed Tomography in Korean COPD PatientsLongitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry.Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smokeCT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society.Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study.The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research
P2860
Q22299234-A19D0E5F-A5E6-4200-95AC-AC85691F427BQ26738405-E4ECB5CD-C4D1-4EF5-A300-35414FA39C54Q26749309-FF842368-0A0C-4B17-9F90-9D3E0CAF737AQ26861010-2483BAD8-9FDB-493A-A987-708DD2EAF362Q27005858-C862D983-F541-479B-A095-C8523DFD223CQ30417798-237B90C5-E846-4018-A180-CC4683CA7832Q30432299-8FA85B50-152D-4B52-B68E-BDCA0758FAF4Q33568625-4BD8D444-7C84-44C0-A49D-46164F467AA1Q33637604-C5D7DFCC-2A51-4BD8-BCE2-9B04244F80F6Q33719462-614B7539-7F45-4874-83F2-F8A667FAE2C9Q33765096-B3D6B23C-5761-47CC-B53F-CA6E899A2299Q33806226-265FEDFE-52E5-4A4C-A70B-C3DCBDA0A049Q33814581-32C53717-38EB-44E9-A862-A7F5EC37EFD6Q34026584-55E3F559-680E-4798-A59C-D24946400794Q34042468-5F5D51CF-403D-492E-BD2D-ABB858AA5093Q34062951-5D2ECFC7-382A-428B-9E6A-80C13A5DE57FQ34343972-674CB1C7-07B0-4663-8364-61615198F968Q34447628-5906E276-31F9-4710-8B70-EA9AB23F729CQ34578635-4BE0EED0-EE0A-4024-A682-8EE71A59A2DAQ34919733-BE47DC61-A661-44BA-B066-11FB0D1D087DQ34999736-BDE86ABB-3370-4E99-BC29-B53D3E924C9CQ35023212-0472FA48-33B6-4C2E-8AC7-7065BCC99068Q35058473-9A107A01-78BA-41BA-A9B9-7FD4F513886FQ35073305-7CA4EDB9-D166-4E0F-A88D-0F6E1DA1002BQ35198572-33270BF5-75CC-4093-B948-6C757434603BQ35275372-A3C9413F-DD78-41DD-B400-BFDAB4C6BBB5Q35412362-DF3654E3-24AA-4DDA-AE37-739B8035DC64Q35587727-82465B49-AF19-4855-8BC6-47EF2B1D3809Q35589135-65E5BFA1-7482-4B06-8C1B-CA2D69EF2FDBQ35665739-B20E0B19-04E1-4070-929B-EF99A525DDB4Q35703799-AA75A2DE-BE57-45C4-A684-0CD025F292B5Q35844059-46D647B5-DCC4-4580-B542-3D51742BC0F4Q35895691-CF6C556E-2B3F-4FD9-93FF-DEDBF809B2D1Q35981766-589B9068-55DE-4CF6-966A-E9B083F7BA97Q36010823-49643874-A297-4AAD-87FD-DF213A7528D5Q36016540-12B28F28-8FB5-41A2-B7D8-C2FBB0C14F72Q36135063-A01A6420-A654-4E9D-8A90-BB348501C3B1Q36185850-8A1FF9D5-1577-403C-BA77-CECBA2C48AAFQ36208552-C3F79FD8-C656-4E0A-931A-1B436C16E326Q36265724-DD337584-FD32-4BA4-B2AD-CABFEB320196
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pulmonary hypertension in COPD.
@en
Pulmonary hypertension in COPD.
@nl
type
label
Pulmonary hypertension in COPD.
@en
Pulmonary hypertension in COPD.
@nl
prefLabel
Pulmonary hypertension in COPD.
@en
Pulmonary hypertension in COPD.
@nl
P2093
P1476
Pulmonary hypertension in COPD.
@en
P2093
E Weitzenblum
P304
P356
10.1183/09031936.00015608
P577
2008-11-01T00:00:00Z